These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7766606)

  • 21. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
    Vix O; Rees B; Thierry JC; Altschuh D
    Proteins; 1993 Apr; 15(4):339-48. PubMed ID: 8460105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
    Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
    J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
    Friedman AR; Roberts VA; Tainer JA
    Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMR observation of interactions in the combining site region of an antibody using a spin-labeled peptide antigen and NOESY difference spectroscopy.
    Scherf T; Hiller R; Anglister J
    FASEB J; 1995 Jan; 9(1):120-6. PubMed ID: 7821751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in crystal properties and ligand affinities of an antifluorescyl Fab (4-4-20) in two solvent systems.
    Gibson AL; Herron JN; He XM; Patrick VA; Mason ML; Lin JN; Kranz DM; Voss EW; Edmundson AB
    Proteins; 1988; 3(3):155-60. PubMed ID: 3255103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties.
    Novotny J; Ganju RK; Smiley ST; Hussey RE; Luther MA; Recny MA; Siliciano RF; Reinherz EL
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8646-50. PubMed ID: 1924326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure to 2.45 A resolution of a monoclonal Fab specific for the Brucella A cell wall polysaccharide antigen.
    Rose DR; Przybylska M; To RJ; Kayden CS; Oomen RP; Vorberg E; Young NM; Bundle DR
    Protein Sci; 1993 Jul; 2(7):1106-13. PubMed ID: 8358294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand binding to anti-fluorescyl antibodies: stability of the antigen binding site.
    Müller JD; Nienhaus GU; Tetin SY; Voss EW
    Biochemistry; 1994 May; 33(20):6221-7. PubMed ID: 8193136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
    Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
    Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oriented Immobilization of Fab Fragments by Site-Specific Biotinylation at the Conserved Nucleotide Binding Site for Enhanced Antigen Detection.
    Mustafaoglu N; Alves NJ; Bilgicer B
    Langmuir; 2015 Sep; 31(35):9728-36. PubMed ID: 26273992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust Antibody-Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking.
    Loyau J; Didelot G; Malinge P; Ravn U; Magistrelli G; Depoisier JF; Pontini G; Poitevin Y; Kosco-Vilbois M; Fischer N; Thore S; Rousseau F
    J Mol Biol; 2015 Aug; 427(16):2647-62. PubMed ID: 26013163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
    Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
    J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.
    Fellouse FA; Wiesmann C; Sidhu SS
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12467-72. PubMed ID: 15306681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
    James LC; Hale G; Waldmann H; Bloomer AC
    J Mol Biol; 1999 Jun; 289(2):293-301. PubMed ID: 10366506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. Crystal structures of native Fab and three Fab-mononucleotide complexes.
    Pokkuluri PR; Bouthillier F; Li Y; Kuderova A; Lee J; Cygler M
    J Mol Biol; 1994 Oct; 243(2):283-97. PubMed ID: 7523684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten.
    Strong RK; Campbell R; Rose DR; Petsko GA; Sharon J; Margolies MN
    Biochemistry; 1991 Apr; 30(15):3739-48. PubMed ID: 2015229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition.
    Ganju RK; Smiley ST; Bajorath J; Novotny J; Reinherz EL
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11552-6. PubMed ID: 1454847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallographic analysis of the NNA7 Fab and proposal for the mode of human blood-group recognition.
    Xie K; Song SC; Spitalnik SL; Wedekind JE
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1386-94. PubMed ID: 16204891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fermenter production of an artificial fab fragment, rationally designed for the antigen cystatin, and its optimized crystallization through constant domain shuffling.
    Schiweck W; Skerra A
    Proteins; 1995 Dec; 23(4):561-5. PubMed ID: 8749852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.